In-depth research, market perspectives, and strategic analysis from the Strategem Advisory team.
Rising feedstock costs, tightening environmental regulations, and shifting demand from Asia-Pacific are creating both headwinds and opportunities for chemical manufacturers worldwide.
With over 1,500 oncology drugs in clinical trials, the competitive pressure is unprecedented. We map the strategic positioning of top players and identify emerging challengers.
India's FMCG sector is on track to reach $220 billion by 2025. We break down the rural-urban divide, premiumisation trend, and distribution dynamics driving this growth.
Geopolitical tensions and demand surges exposed critical vulnerabilities in global semiconductor supply chains. This report examines best practices from leading manufacturers.
The EV transition is accelerating faster than expected in key markets. We analyze demand forecasts, battery technology trends, and the competitive positions of legacy OEMs vs. new entrants.
Rare diseases represent a high-value, high-complexity opportunity. We explore regulatory pathways, pricing strategies, and competitive moats that define success in this space.
We tailor every project to your specific market, geography, and business question. Let's discuss what you need.
Talk to an analyst